WETS
NVAX icon

Wealth Enhancement Trust Services’s Novavax NVAX Stock Holding History

Wealth Enhancement Trust Services’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.1K Buy
+117
New +$1.05K ﹤0.01% 1112

Other funds holding NVAX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TCMG
TSP Capital Management Group Summit, New Jersey $418M AUM 68.45% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return

Wealth Enhancement Trust Services's NVAX Position: Q2 2026 in Review

Wealth Enhancement Trust Services opened a new position in Novavax (NVAX) in Q2 2026: 117 shares worth $1.1K. The stake represents ﹤0.01% of the portfolio and ranks #1112 among its holdings.

165 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Wealth Enhancement Trust Services held 117 shares of Novavax worth $1.1K as of Q2 2026.
  • Novavax was a new Wealth Enhancement Trust Services position in Q2 2026.
  • Novavax made up ﹤0.01% of Wealth Enhancement Trust Services's portfolio in Q2 2026, its #1112 holding.
  • 165 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q2 2026, filed 15 Jul 2026.